RPCG PCL F (R4Q) - Net Assets
Based on the latest financial reports, RPCG PCL F (R4Q) has net assets worth €3.77 Billion EUR (≈ $4.40 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€8.82 Billion ≈ $10.32 Billion USD) and total liabilities (€5.06 Billion ≈ $5.91 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check R4Q goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €3.77 Billion |
| % of Total Assets | 42.68% |
| Annual Growth Rate | 12.48% |
| 5-Year Change | 52.5% |
| 10-Year Change | N/A |
| Growth Volatility | 22.64 |
RPCG PCL F - Net Assets Trend (2016–2025)
This chart illustrates how RPCG PCL F's net assets have evolved over time, based on quarterly financial data. See RPCG PCL F defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for RPCG PCL F (2016–2025)
The table below shows the annual net assets of RPCG PCL F from 2016 to 2025. For live valuation and market cap data, see R4Q market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €3.77 Billion ≈ $4.40 Billion |
-2.74% |
| 2024-12-31 | €3.87 Billion ≈ $4.53 Billion |
-3.13% |
| 2023-12-31 | €4.00 Billion ≈ $4.67 Billion |
+62.88% |
| 2022-12-31 | €2.45 Billion ≈ $2.87 Billion |
-0.63% |
| 2021-12-31 | €2.47 Billion ≈ $2.89 Billion |
+41.22% |
| 2020-12-31 | €1.75 Billion ≈ $2.04 Billion |
+0.94% |
| 2019-12-31 | €1.73 Billion ≈ $2.03 Billion |
+28.60% |
| 2018-12-31 | €1.35 Billion ≈ $1.57 Billion |
+2.78% |
| 2017-12-31 | €1.31 Billion ≈ $1.53 Billion |
+0.28% |
| 2016-12-31 | €1.31 Billion ≈ $1.53 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to RPCG PCL F's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 119669506000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €732.42 Million | 32.08% |
| Other Components | €1.55 Billion | 67.92% |
| Total Equity | €2.28 Billion | 100.00% |
RPCG PCL F Competitors by Market Cap
The table below lists competitors of RPCG PCL F ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
GCM Grosvenor Inc
NASDAQ:GCMGW
|
$85.77 |
|
Neovacs S.A.
PA:ALNEV
|
$95.00 |
|
Us1 Critical Minerals Limited
AU:USC
|
$108.70 |
|
Versus Systems Inc
NASDAQ:VSSYW
|
$110.89 |
|
Ordinary Fully Paid Deferred Settlement
AU:CNJDG
|
$76.87 |
|
Innoviz Technologies Ltd
NASDAQ:INVZW
|
$72.56 |
|
Nuvve Holding Corp
NASDAQ:NVVEW
|
$68.61 |
|
Jack Nathan Medical Corp
V:JNH
|
$65.37 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in RPCG PCL F's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 2,352,168,578 to 2,282,813,441, a change of -69,355,137 (-2.9%).
- Net loss of 52,750,165 reduced equity.
- Dividend payments of 13,046,378 reduced retained earnings.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-52.75 Million | -2.31% |
| Dividends Paid | €13.05 Million | -0.57% |
| Other Changes | €-3.56 Million | -0.16% |
| Total Change | €- | -2.95% |
Book Value vs Market Value Analysis
This analysis compares RPCG PCL F's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €0.99 | €0.01 | x |
| 2018-12-31 | €1.02 | €0.01 | x |
| 2019-12-31 | €1.32 | €0.01 | x |
| 2020-12-31 | €1.34 | €0.01 | x |
| 2021-12-31 | €1.89 | €0.01 | x |
| 2022-12-31 | €1.88 | €0.01 | x |
| 2023-12-31 | €1.90 | €0.01 | x |
| 2024-12-31 | €1.80 | €0.01 | x |
| 2025-12-31 | €1.75 | €0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently RPCG PCL F utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -2.31%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -0.63%
- • Asset Turnover: 0.95x
- • Equity Multiplier: 3.87x
- Recent ROE (-2.31%) is below the historical average (4.24%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | -5.36% | -3.07% | 0.71x | 2.45x | €-198.51 Million |
| 2017 | -2.83% | -1.50% | 0.78x | 2.41x | €-166.36 Million |
| 2018 | -0.67% | -0.27% | 0.92x | 2.65x | €-142.26 Million |
| 2019 | 22.15% | 8.89% | 1.05x | 2.36x | €208.91 Million |
| 2020 | 2.54% | 1.06% | 0.90x | 2.66x | €-130.52 Million |
| 2021 | 28.19% | 12.70% | 1.38x | 1.61x | €449.03 Million |
| 2022 | 2.61% | 0.82% | 1.89x | 1.68x | €-181.37 Million |
| 2023 | 1.12% | 0.27% | 1.14x | 3.64x | €-220.11 Million |
| 2024 | -3.06% | -0.81% | 0.93x | 4.05x | €-307.14 Million |
| 2025 | -2.31% | -0.63% | 0.95x | 3.87x | €-281.03 Million |
Industry Comparison
This section compares RPCG PCL F's net assets metrics with peer companies in the Specialty Retail industry.
Industry Context
- Industry: Specialty Retail
- Average net assets among peers: $1,300,396,749
- Average return on equity (ROE) among peers: 19.36%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| RPCG PCL F (R4Q) | €3.77 Billion | -5.36% | 1.34x | $81.40 |
| BAPCOR LTD. (0BS) | $894.34 Million | -17.70% | 1.13x | $163.60 Million |
| JUMBO SA UNSP.ADR/1 O.N. (5JB1) | $1.33 Billion | 16.31% | 0.35x | $3.23 Billion |
| TERACT EO 1 (6O8) | $142.10 Million | 24.42% | 5.60x | $206.71 Million |
| SEALAND CAP. GA. LS-0001 (7KM) | $-1.58 Million | 0.00% | 0.00x | $654.74K |
| SFD SA ZY -10 (7PQ) | $49.49 Million | 12.64% | 1.46x | $24.75 Million |
| BETTERWARE DE MEXICO SAPI (BM0) | $1.46 Billion | 71.05% | 6.58x | $521.41 Million |
| Brüder Mannesmann Aktiengesellschaft (BMM) | $10.65 Million | 19.12% | 2.89x | $4.28 Million |
| Ceconomy AG (CEC) | $6.44 Billion | 9.80% | 4.28x | $1.86 Billion |
| DUFRY AG UNSP.ADR/010 (D2JA) | $2.50 Billion | 3.49% | 5.62x | $7.78 Billion |
| Dunelm Group plc (DFQ) | $185.80 Million | 54.52% | 1.24x | $2.21 Billion |
About RPCG PCL F
RPCG Public Company Limited, together with its subsidiaries, engages in the energy and real estate businesses in Thailand. It operates through Energy, Real Estate Development, Rental, Service, and Restaurant and Bakery segments. The company is involved in the manufacture and distribution of biodiesel and crude glycerin; Pico plus business; retail of fuel and gas through a network of gas stations;… Read more